Drug Profile
Research programme: glucosamine-6-phosphate synthase inhibitors - Gdansk/BTG
Alternative Names: Glucosamine-6-phosphate synthase inhibitors research programme - Gdansk/BTGLatest Information Update: 30 Aug 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action Glucosamine-6-phosphate synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Candidiasis
Most Recent Events
- 04 Jun 1999 These compounds are available for licensing from BTG (http://www.btgplc.com)
- 28 May 1999 Preclinical development for Candidiasis in Poland (Unknown route)